Latest Articles

  • Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events
    Ki Park, MD and Anthony A. Bavry, MD, MPH
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 318-326; DOI: https://doi.org/10.3949/ccjm.80a.12146

    Aspirin’s benefits in primary prevention are not as clear as in secondary prevention, particularly in people with diabetes, in women, and in the elderly.

  • Preserving fertility in female cancer patients: A snapshot of the options
    Ilaria Soave, MD, Giuseppe Lo Monte, MD, Emilio Giugliano, MD, Angela Graziano, MD and Roberto Marci, PhD
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 309-317; DOI: https://doi.org/10.3949/ccjm.80a.12065

    With the odds of surviving cancer improving, many young women facing therapy may first wish to take steps to ensure that they will still be able to bear children afterward.

  • A review of uncommon swelling provides useful reminders
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 261; DOI: https://doi.org/10.3949/ccjm.80b.05013

    Angioedema and the urticarias differ in their clinical manifestations and diagnostic and therapeutic implications.

  • Hyperpigmented patches on the neck, shoulder, and back
    Jason M. Rizzo, BS, Lesley C. Loss, MD and Ilene L. Rothman, MD
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 290-296; DOI: https://doi.org/10.3949/ccjm.80a.12033

    A 17-year-old boy has had asymptomatic, unilateral hyperpigmented patches since birth. What is the diagnosis?

  • Not all joint pain is arthritis
    Gursimran S. Kochhar, MD, Maged Rizk, MD and Deepa T. Patil, MD
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 272-273; DOI: https://doi.org/10.3949/ccjm.80a.12085

    A 47-year-old man who was diagnosed with rheumatoid arthritis 5 years ago now has pleural effusions and abdominal pain.

  • What should be the interval between bone density screenings?
    Susan M. Ott, MD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 240-242; DOI: https://doi.org/10.3949/ccjm.80a.12166

    Doctors should not order unnecessary and expensive tests and should not recommend frequent repeated testing that does not benefit the patient.

  • Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients
    Federico Perez, MD and David Van Duin, MD, PhD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 225-233; DOI: https://doi.org/10.3949/ccjm.80a.12182

    The emergence of carbapenem-resistant Enterobacteriaceae (CRE) highlights the importance of effective antibiotics to maintain the safety of our health care system. Clinicians will encounter CRE as a cause of difficult-to-treat and often fatal infections in hospitalized patients. We review the mechanisms of carbapenem resistance, the dissemination and clinical impact of these resistant organisms, and challenges to their detection, treatment, and control.

  • Options for managing severe aortic stenosis: A case-based review
    Options for managing severe aortic stenosis: A case-based review
    Olcay Aksoy, MD, Bridget L. O’brien, MD, FACC and Venu Menon, MD, FACC, FAHA
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 243-252; DOI: https://doi.org/10.3949/ccjm.80a.12078

    Today, patients who cannot undergo surgery can be offered a variety of less invasive treatments. We use seven cases to illustrate how to manage these patients.

  • A rapidly growing crusted nodule on the lip
    Paul J. Wirth and Thomas N. Helm, MD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 222-224; DOI: https://doi.org/10.3949/ccjm.80a.12050

    The patient, who had a squamous cell carcinoma, underwent Mohs surgery and has done well.

  • Bone mineral density testing: Is a T score enough to determine the screening interval?
    Krupa B. Doshi, MD, CCD, Leila Z. Khan, MD, CCD, Susan E. Williams, MS, MD, CCD and Angelo A. Licata, MD, PhD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 234-239; DOI: https://doi.org/10.3949/ccjm.80a.12069

    Although a trial found that women with normal or only slightly low results need not come back for another 15 years, it may not be so simple.

Pages